NCT05458193View on ClinicalTrials.gov

A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Obstructive Sleep Apnea of Adult
Interventions
DRUG

Daridorexant

Film-coated tablet for oral use

DRUG

Placebo

Film-coated tablet for oral use

Trial Locations (1)

10117

ASR Advanced Sleep Research GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY